World-class technology. ProFound outcomes.
As a radiologist, you understand the importance of looking closely to determine the truth.
For more than 20 years, iCAD has built a legacy of global leadership delivering transformative innovations built on artificial intelligence to detect cancer earlier. Our complete focus is on empowering you with state-of-the-art deep-learning technologies expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.
At RSNA this year, we invite you to look beyond the hype and experience ProFound confidence in your AI solutions, without compromise.
From the world leader in artificial intelligence for breast imaging, discover the ProFound impact iCAD’s award-winning portfolio of cancer detection, density assessment, and risk evaluation solutions can have on your reading workflow.
AccurateUnrivaled by any other AI solution available today, ProFound AI improves radiologists’ sensitivity by 8 percent, and reduces false positives and unnecessary patient recall rates by 7.2 percent.The latest version offers up to a 10% incremental improvement in specificity performance while maintaining an industry-leading high sensitivity level.EfficientProFound AI delivers unmatched, clinically proven time-savings benefits to radiologists, slashing reading time by 52.7%.Further, Certainty of Finding and Case Scores assist in prioritizing caseload and clinical decision-making, reducing physician burnout.Multi-VendorWith thousands of installations worldwide, ProFound AI offers multi-vendor compatibility and seamlessly integrates into the diagnostic process.Our commitment to integrate with all major mammography system vendors and enterprise-wide viewing applications empowers hospitals and imaging centers everywhere with a proven, standardized AI solution primed to scale.Now compatible with
Hologic Clarity HD!FlexibleToday’s unprecedented screening challenges call for unparalleled AI solutions, streamlining workflow and elevating outcomes.ProFound AI flexibly integrates with major PACS, offering an intuitive, system-wide solution for improved workflow and decision support in any reading environment.ScalableWith market leading agility, ProFound AI offers a practical enterprise-wide solution with powerful results.With access to our complete portfolio of cancer detection, density assessment and risk evaluation solutions on one centralized server, streamlined deployment of state-of-the-art breast imaging technology at scale is simple.EquitableNow available for 2D and 3D mammography, ProFound AI® Risk is the world’s first clinical decision support tool that provides an accurate short-term, breast cancer risk estimation that is truly personalized for each woman.Specifically designed to factor in racial and ethnic backgrounds, ProFound AI Risk offers an inclusive, first-in-kind approach to precision screening.
What’s better than Clarity? Certainty.
Experience high-performance AI
for high-resolution imaging.
Now compatible with the Hologic Clarity HD high-resolution imaging suite!
Cocktails & Conversations
Join us for a series of cocktail receptions for an opportunity to meet leading AI experts in breast imaging.
Monday, November 29& Tuesday, November 305:30pm CTFatpour Tap Works McCormick2206 S. Indiana Ave, Chicago, IL
Advanced RSVP preferred. Space is limited.
Learn More at Clinical Presentations
Session ID: SPR-BR-4: Use Of Artificial Intelligence Software To Identify Clinically Aggressive Lesions On Prior Digital Breast Tomosynthesis Exams Based On Molecular Subtypes
Tuesday, November 30th, 12:15 - 12:45 PM, Session ID: BR03-A2:
Effect Of Artificial Intelligence Software On Digital Breast Tomosynthesis Screening Cancer Detection And Abnormal Interpretation Rates Among Subspecialized Breast Radiologists: A Real World Experience
Tuesday, November 30th, 12:45 - 1:15 PM, Session ID: BR03-B3:
Tomosynthesis-driven AI-derived Breast Cancer Scoring Among A Racially Diverse Cohort Of Women Undergoing Screening: Potential For Triage And Precision Cancer Screening
A ProFound Legacy of Leadership
of AI market leadership50+
global patents7,000+ installations worldwideThe latest version of ProFound AI was developed using more than 5 million images from 30,000 cases, including almost 8,000 biopsy-proven cancers, and is continuously improving.
Pre-book an in-person or virtual meeting for a daily chance to win a $250 gift card of your choice.*
Find us in the South Hall Meeting Suites next to the AI Showcase.
© iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.